Director of Science • Chair @UKQSAR • FRSA FRSB FRSC • 🏴🇩🇰🇪🇺
Aarhus, Denmark
Joined January 2009
- Tweets50.2K
- Following2.9K
- Followers5K
- Likes14.8K
🔬 Exploring Edinburgh Through a Scientific Lens 🧪
#UKQSAR & #Cheminformatics meeting in Edinburgh: experience the city in a slightly different way?
📍 Take it at your own pace
🌍 A great way to connect science with history
👉 Access the tour here: doi.org/10.5281/zenodo.19550…
🧪 How we represent chemistry shapes discovery.
SMILES → GNNs → foundation models.
📍 RSC CICAG Chemical Structure Representations Meeting 2026
📅 8 April | London
🔗 registrations.hg3conferences…
Delighted to be joining #Optibrium as their new Director of Science! optibrium.com/about/news/nat…
#ArtificialIntelligence #MachineLearning #AI #ML #DrugDiscovery
New fireside chat with AWS on how drug discovery is shifting from trial-and-error labs to computation, algorithms, and AI-driven molecular design.
I touch on why chemistry-as-data matters and why data access is now the biggest bottleneck.
youtu.be/18ZcYxOQtaE
Travelling to Frankfurt to present at Certainty Discovery 2025 tomorrow morning: chemaxon.com/certainty-disco…
Looking forward to meeting old friends and making new ones. I’ll be presenting on human centric design for drug discovery platforms. I’ll she my slides later.
🚀 Healx is launching a new blog series on practical, open-source workflows for drug discovery! First up: a KNIME + ChEMBL pipeline to explore compound-target interactions. Big thanks to #RDKit, ChEMBL, UniChem & KNIME! 🧪 Read more: medium.com/low-code-for-adva…
Nathan Brown retweeted
Spring UK-QSAR meeting: Registration is now open! Find out more here
ukqsar.org/index.php/2025/03…
📆 Tuesday 15th April 2025
📍Francis Crick Institute, London
#ukqsar #compchem #cheminformatics #chemoinformatics
Nathan Brown retweeted
From shared vision to changing lives.
In 2013, our co-founders Dr. David Brown & Tim Guilliams met for the first time — a conversation that sparked the creation of Healx and a new approach to discovering and developing treatments for rare diseases.
Now, we’ve just dosed the first patient in our Phase 2 trial for HLX-1502, our investigational therapy for #NF1.
Watch Dr. Brown share the story & our progress.
#RareDisease #NF1 #Biotech #DrugDiscovery
“We must take sides. Neutrality helps the oppressor, never the victim. Silence encourages the tormentor, never the tormented. Sometimes we must interfere. When human lives are endangered, when human dignity is in jeopardy, national borders and sensitivities become irrelevant.
Nathan Brown retweeted
🚀 Big milestone! The first patient has been dosed in INSPIRE-NF1, our Phase 2 study of HLX-1502 for #NF1, a rare genetic disorder affecting ~1 in 2,500 people.
This is a huge step forward in our mission to use #AI & tech to drive breakthroughs for #raredisease patients.
Hear from our co-founder & CEO Tim Guilliams on why this matters.
🔗 healx.ai/healx-announces-fir…
#NF1Awareness #Biotech #Innovation #AIforGood #RareDiseases
Nathan Brown retweeted
In honor of International Day of Women and Girls in Science, we’re celebrating the incredible women at Healx who are helping to pave the way in AI-driven drug discovery for #rarediseases. We believe in fostering a more inclusive future where women and girls are empowered to shape the next breakthroughs in science and technology, we’re proud to support a workplace where diverse perspectives drive progress and impact. #IDWGS #WomenInScience
The new issue of @RSC_CICAG Distillate has been published. It’s full
Of useful information and updates:
rsccicag.org/index_htm_files…
#cheminformatics #chemoinformatics #compchem #medchem
Nathan Brown retweeted
Excited for #JPM25 next week in San Francisco!
Our CEO, Tim Guilliams, will be there—say hello if you see him! Let’s connect to share insights and collaborate on transforming lives for #raredisease patients through generative #AI. #AIForGood #HealthcareInnovation @jpmorganhealth
Nathan Brown retweeted
Another quarterly team days meeting in the books! We enjoyed coming together in Cambridge one final time before the end of the year to reflect on the progress made in 2024 and the strides we have made in leveraging the power of generative AI to bring new treatments to patients. Our advancements wouldn’t be possible without the dedication and passion of this talented team and the partnerships we’ve fostered with organisations and collaborators around the world. And to top it all off, even Father Christmas stopped by to celebrate the season and the team’s hard work!
Nathan Brown retweeted
Our co-founder and CEO Tim Guilliams is looking forward to participating in a panel discussion on how #AI is reshaping healthcare at @Balderton’s “From code to cure: AI's reshaping of drug discovery” event in London. Tim will highlight how Healx is leveraging generative AI to build a pipeline of patient-inspired treatments for #rarediseases
Great to have Jonathan stepping up as non-executive chairman at Healx as Dave goes on secondment!
We are pleased to announce the appointment of Jonathan Milner, Ph.D., as the new non-executive chairman of the board, effective immediately. Dr. Milner is a distinguished entrepreneur and an influential figure in the UK life sciences and #biotech industry with a strong track record of fostering innovation. In addition to serving on several boards, he has contributed his expertise to numerous startups and established organisations, and we are grateful to have him at Healx.
This transition comes as current chairman and co-founder David Brown, Ph.D., begins a secondment to pursue academic research at Trinity College, Cambridge University. Dr. Brown will remain an active member of the Healx board, continuing to contribute and support Tim Guilliams, Ph.D., co-founder and CEO of Healx, and Dr. Milner in advancing Healx’s mission.
Read more about this update here: healx.ai/jonathan-milner-ph-…
Working with Dave is inspirational and he always has fascinating insights. Congratulations, Dave!
We're extending our sincerest congratulations to Healx Co-founder David Brown, Ph.D., for being awarded the 2024 @OBN_UK Awards Special Recognition Award. Over the span of 50 years, and in addition to his leadership at Healx, he has worked with leading pharmaceutical companies and is responsible for many tremendous achievements, including the co-invention of Viagra during his time at Pfizer. His many accomplishments include improving access to medicines in less advantaged countries, sponsoring a global challenge to find innovative treatments for sepsis, and becoming an entrepreneur coach at Cambridge University Business School.
We're grateful to work closely with Dr. Brown as he helps guide our mission of creating generative AI-powered, patient-inspired treatments for people living with #rarediseases.